|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/195 | (2006.01) |
| A61K 31/197 | (2006.01) | ||
| A61P 35/04 | (2006.01) |
| (11) | Patento numeris | 3432872 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17770846.8 |
| Europos patento paraiškos padavimo data | 2017-03-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-01-30 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-08-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/022718 |
| Data | 2017-03-16 |
| (87) | Numeris | WO 2017/165187 |
| Data | 2017-09-28 |
| (30) | Numeris | Data | Šalis |
| 201662312623 P | 2016-03-24 | US |
| (72) |
LEVIN, Victor, A. , US
|
| (73) |
Orbus Therapeutics, Inc. ,
2475 East Bayshore Road
Suite 105, Palo Alto, CA 94303,
US
|
| (54) | EFLORNITHINE FOR USE IN THE TREATMENT OF TEMOZOLOMIDE RECURRENT/REFRACTORY ANAPLASTIC ASTROCYTOMA |
| EFLORNITHINE FOR USE IN THE TREATMENT OF TEMOZOLOMIDE RECURRENT/REFRACTORY ANAPLASTIC ASTROCYTOMA |